EXEL vs LYB · P/E 17, rev $1.24B vs P/E 21, rev $16.37B
Exelixis Inc (EXEL) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $1.24B. Net income was $422.5M. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the EXEL and LYB stock pages for the full models.
Not investment advice.